Assessing the utility of the Primary Care PTSD Screen for DSM‐5 (PC‐PTSD‐5) as a screening tool among caregivers of hematopoietic stem cell transplantation survivors
Cancer · 2026
DOI: 10.1002/cncr.70285 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cancer, 2026. Verfasst von Allison J Applebaum und 7 weiteren Autor:innen. Beteiligte Einrichtung: Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Cancer Survivors, Caregivers, Hematopoietic Stem Cell Transplantation, Stress Disorders, Post-Traumatic. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Duke University School of Nursing.
Abstract (Originalsprache)
Background
Hematopoietic stem cell transplantation (HCT) is an intensive and invasive procedure used in cancer treatment that depends heavily on the involvement of caregivers and places them at high risk for posttraumatic stress disorder (PTSD) symptoms. These symptoms are frequently overlooked in oncology and general health care settings. The suitability and utility of the Primary Care PTSD Screen for DSM ‐ 5 (PC‐PTSD‐5) within cancer caregivers remains uncertain. This study sought to evaluate its performance as a brief (five‐item) case finding screening alternative to the longer (20‐item) PTSD Checklist for DSM‐5 (PCL‐5) in caregivers of survivors who received an HCT 1–5 years ago.
Method
A total of 106 caregivers completed the PC‐PTSD‐5 and PCL‐5 during recruitment for a randomized clinical trial. Optimal cut scores for identifying probable PTSD and item performance were determined using indices correcting for chance and item response theory analyses.
Results
Of the caregivers evaluated, 33% screened as positive for probable DSM‐5 PTSD using the PCL‐5. The PC‐PTSD‐5 exhibited acceptable internal consistency and significant associations with PCL‐5 scores (total, r = 0.79; items r [range] [0.60–0.69]). A cutoff score of 3 provided optimal sensitivity for screening (κ[Se] = 1). Item response theory analyses indicated the need for the complete PC‐PTSD‐5 items to provide the greatest information across varying levels of PTSD.
Conclusion
Although not an instrument validation study, these findings provide preliminary support for using the PC‐PTSD‐5 as a succinct, effective screening tool among cancer caregivers in a clinical context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Biostatistics and Research Decision Sciences (BARDS), Merck & Co., Inc, Rahway, New Jersey, USA.
- Dissemination and Training Division, National Center for PTSD, Palo Alto, California, USA.
- Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford, California, USA.
- Statistical Sciences and Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.
- Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
ORCID-Profile: Allison J Applebaum, Leah E Walsh, Tamara J Somers, Sophia K Smith
Förderung
- NCI NIH HHS
- Duke University School of Nursing
Zitieren
APA
Applebaum, A. J., Manschot, C., Kuhn, E., Laber, E., Walsh, L. E., Somers, T. J., Syrjala, K. L., & Smith, S. K. (2026). Assessing the utility of the Primary Care PTSD Screen for DSM‐5 (PC‐PTSD‐5) as a screening tool among caregivers of hematopoietic stem cell transplantation survivors. Cancer. https://doi.org/10.1002/cncr.70285
Vancouver
Applebaum AJ, Manschot C, Kuhn E, Laber E, Walsh LE, Somers TJ, et al. Assessing the utility of the Primary Care PTSD Screen for DSM‐5 (PC‐PTSD‐5) as a screening tool among caregivers of hematopoietic stem cell transplantation survivors. Cancer. 2026. doi:10.1002/cncr.70285
BibTeX
@article{Applebaum2026,
author = {Applebaum, Allison J and Manschot, Cole and Kuhn, Eric and Laber, Eric and Walsh, Leah E and Somers, Tamara J and Syrjala, Karen L and Smith, Sophia K},
title = {Assessing the utility of the Primary Care PTSD Screen for DSM‐5 (PC‐PTSD‐5) as a screening tool among caregivers of hematopoietic stem cell transplantation survivors},
journal = {Cancer},
year = {2026},
doi = {10.1002/cncr.70285}
}
EUVIMED